Hillstream BioPharma Net Tangible Assets

Hillstream BioPharma (HILS) currently reports a net tangible assets of $450M as of June 2026. That compares with $370K in the prior-year period — up 123730.5% year over year. Use the charts on this page to explore Hillstream BioPharma's net tangible assets history and peer comparisons.

Hillstream BioPharma's net tangible assets increased from $370K to $450M — a 123730.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hillstream BioPharma reported $450M in net tangible assets as of June 2026. That compares with $370K in the prior-year period — up 123730.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $450M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hillstream BioPharma, and consider following HILS for alerts when major investors trade the stock.